Long non-coding RNA OGFRP1 regulates LYPD3 expression by sponging miR-124-3p and promotes non-small cell lung cancer progression

被引:53
作者
Tang, Li-Xin [1 ]
Chen, Guo-Hua [1 ]
Li, Huan [1 ]
He, Ping [2 ]
Zhang, Yan [3 ]
Xu, Xue-Wen [4 ]
机构
[1] Chongqing Publ Hlth Med Ctr, Dept Resp Geriatr, Chongqing 400000, Peoples R China
[2] Chongqing Southwest Hosp, Dept Cardiothorac Surg, Chongqing 400000, Peoples R China
[3] Chongqing Jalin Hosp, Dept Med, Chongqing 400000, Peoples R China
[4] Chongqing Publ Hlth Med Ctr, Dept Anesthesiol, 1 Huangjuewan Rd, Chongqing 400000, Peoples R China
关键词
LncRNA OGFRP1; Non-small cell lung cancer; Prognosis; miR-124-3p; Metastasis; LYPD3; IMMUNOTHERAPY; STATISTICS; MICRORNAS; AXIS;
D O I
10.1016/j.bbrc.2018.09.146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long noncoding RNA (OGFRP1) has been reported to be involved in the progression of non-small cell lung cancer (NSCLC). However, the expression pattern, functions and molecular mechanisms of OGFRP1 in NSCLC remains unclear. In the present study, we found that OGFRP1 expression was significantly upregulated in both NSCLC tissues and cell lines, and the upregulation of OGFRP1 expression is a powerful predictor of advanced clinical stage, lymph nodes metastasis and poor prognosis for NSCLC patients. Loss-of-function assay indicated that knockdown of OGFRP1 inhibited proliferation, migration and invasion, and induced apoptosis in vitro. Mechanistically, OGFRP1 could directly bind to miR-124-3p and effectively act as a competing endogenous RNA (ceRNA) for miR-124-3p to promote the expression of the target gene LYPD3. Taken together, OGFRP1 contributed to progression of NSCLC at least partly through upregulating LYPD3 expression by sponging miR-124-3p, indicating that OGFRP1 may be a novel prognostic biomarker and therapeutic target in NSCLC. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 25 条
[1]   Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non-Small Cell Lung Cancer [J].
Anagnostou, Valsamo K. ;
Brahmer, Julie R. .
CLINICAL CANCER RESEARCH, 2015, 21 (05) :976-984
[2]  
[Anonymous], BR J NURS
[3]  
[Anonymous], BR J NURS
[4]   Emerging Role of MicroRNAs and Long Noncoding RNAs in Respiratory Disease [J].
Booton, Richard ;
Lindsay, Mark A. .
CHEST, 2014, 146 (01) :193-204
[5]   Long noncoding RNAs and the genetics of cancer [J].
Cheetham, S. W. ;
Gruhl, F. ;
Mattick, J. S. ;
Dinger, M. E. .
BRITISH JOURNAL OF CANCER, 2013, 108 (12) :2419-2425
[6]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[7]   Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways [J].
Chen, Wei ;
You, Jia ;
Zheng, Qi ;
Zhu, Yue-Yong .
CANCER MANAGEMENT AND RESEARCH, 2018, 10 :1817-1826
[8]  
Evans Michael, 2013, Br J Nurs, V22, pS15
[9]   Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression [J].
Fang, Jing ;
Sun, Cheng-Cao ;
Gong, Cheng .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (02) :811-817
[10]   Vaccine immunotherapy in lung cancer: Clinical experience and future directions [J].
Freeman-Keller, Morganna ;
Goldman, Jamie ;
Gray, Jhanelle .
PHARMACOLOGY & THERAPEUTICS, 2015, 153 :1-9